
LIVING WITH SCHIZOPHRENIA?
Life with schizophrenia can be challenging. Medications often come with unwanted side effects, but a new generation of schizophrenia medication may be on the way. Want to help in the research efforts? If you take medication for schizophrenia, you may qualify.
See If You Qualify
Fill out the form below to see if you meet the basic study requirements.

What’s involved?
To participate in one or more of the studies, you will need to:
Why Participate?
As a participant, you would get the opportunity to help with important schizophrenia medication research. Depending on your location, there may be multiple study opportunities available that include inpatient stays and care of between 8-60 days. Compensation is also available for your participation.
Frequently Asked questions?
Yes, the study requires that you have been on a stable dose of certain qualifying medications for at least 8 weeks.
The length of study participation varies by study, and participants may be able to participate in more than one. Each study requires 2 screening visits, followed by an inpatient stay of a minimum of 8 to a maximum of 60 days, and an additional follow-up visit.
Yes, there is compensation available for participation and travel. Compensation amounts are determined on a site by site basis. Please check with your site for more information.
Yes, participation is completely voluntary and can be ended at any time.
Some research sites are hospital based, so the experience would be similar to an extended hospital stay. However, some sites are dedicated research facilities which include a gym, meals catered, family environment, and outdoor time. Check with your local site location during your screening call for more information.
Please note: 1nHealth may store your data in a confidential and secure database. That personal information will never be shared or sold with any other persons or organizations not associated with 1nHealth. 1nHealth may/will use personal information to contact you directly by phone and/or email for matters related to potential participation in clinical trials, studies, and projects for which the potential participant may qualify. See our Privacy Policy for more details.